Pulmonary vein isolation (PVI) is the cornerstone of catheter ablation for both symptomatic paroxysmal (intermittent episodes of AF) and persistent AF. During the procedure, catheters are inserted ...

That wouldn’t be for all patients undergoing AF ablation, he clarified, estimating that about 80% of PVI cases could be done with same-day discharge and 20% would require the patient to stay in the ...

whereas those in the aggressive treatment group underwent PVI, anatomical ablation, and extensive electrogram-guided ablation. The primary endpoint was freedom from any episode of AF or AT lasting ...

Volta Medical, a pioneering health technology company developing artificial intelligence (AI) solutions to assist electrophysiologists in assessing complex cardiac arrhythmias such as atrial ...

US healthtech giant Boston Scientific’s pulmonary vein isolation (PVI) device trial has met its primary endpoint in patients with paroxysmal atrial fibrillation (AF) as the company looks to ...

ACE-I: Angiotensin-converting enzyme inhibitor; ARB: Angiotensin receptor blocker; AF: Atrial fibrillation ... Persistent atrial fibrillation; PVI: Pulmonary vein isolation; RAAS: Reninangiotensin ...

Volta Medical, a pioneering health technology company developing artificial intelligence (AI) solutions to assist electrophysiologists, today announced the appointment of Bill Hoffman as Executive Cha ...